US Bancorp’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75K | Hold |
1,250
| – | – | ﹤0.01% | 3878 |
|
|
2025
Q1 | $2.21K | Hold |
1,250
| – | – | ﹤0.01% | 3841 |
|
|
2024
Q4 | $2.88K | Hold |
1,250
| – | – | ﹤0.01% | 3778 |
|
|
2024
Q3 | $4.43K | Hold |
1,250
| – | – | ﹤0.01% | 3597 |
|
|
2024
Q2 | $3.46K | Hold |
1,250
| – | – | ﹤0.01% | 3587 |
|
|
2024
Q1 | $8.29K | Hold |
1,250
| – | – | ﹤0.01% | 3386 |
|
|
2023
Q4 | $3.81K | Hold |
1,250
| – | – | ﹤0.01% | 3580 |
|
|
2023
Q3 | $1.9K | Hold |
1,250
| – | – | ﹤0.01% | 3645 |
|
|
2023
Q2 | $2.24K | Hold |
1,250
| – | – | ﹤0.01% | 3628 |
|
|
2023
Q1 | $1.55K | Hold |
1,250
| – | – | ﹤0.01% | 3792 |
|
|
2022
Q4 | $2.96K | Hold |
1,250
| – | – | ﹤0.01% | 3655 |
|
|
2022
Q3 | $5K | Hold |
1,250
| – | – | ﹤0.01% | 3608 |
|
|
2022
Q2 | $7K | Hold |
1,250
| – | – | ﹤0.01% | 3473 |
|
|
2022
Q1 | $13K | Hold |
1,250
| – | – | ﹤0.01% | 3279 |
|
|
2021
Q4 | $14K | Hold |
1,250
| – | – | ﹤0.01% | 3283 |
|
|
2021
Q3 | $26K | Hold |
1,250
| – | – | ﹤0.01% | 2986 |
|
|
2021
Q2 | $31K | Hold |
1,250
| – | – | ﹤0.01% | 2902 |
|
|
2021
Q1 | $36K | Hold |
1,250
| – | – | ﹤0.01% | 2743 |
|
|
2020
Q4 | $26K | Hold |
1,250
| – | – | ﹤0.01% | 2786 |
|
|
2020
Q3 | $32K | Hold |
1,250
| – | – | ﹤0.01% | 2570 |
|
|
2020
Q2 | $30K | Hold |
1,250
| – | – | ﹤0.01% | 2594 |
|
|
2020
Q1 | $8K | Hold |
1,250
| – | – | ﹤0.01% | 3050 |
|
|
2019
Q4 | $14K | Hold |
1,250
| – | – | ﹤0.01% | 2975 |
|
|
2019
Q3 | $17K | Hold |
1,250
| – | – | ﹤0.01% | 2909 |
|
|
2019
Q2 | $18K | Buy |
+1,250
| New | +$18K | ﹤0.01% | 2928 |
|